Albert N Marchio Ii is CEO and CFO of Fresh Tracks Therapeutics, Inc.
Person profile
Latest filings (excl ownership)
No filings
Latest ownership filings
3
NexImmune, Inc.
10 Apr 24
4
Fresh Tracks Therapeutics, Inc.
9 Jan 24
4
Fresh Tracks Therapeutics, Inc.
26 Jan 23
4
Brickell Biotech, Inc.
9 May 22
4
Brickell Biotech, Inc.
14 Jun 21
3
Brickell Biotech, Inc.
10 Dec 20
4/A
Edge Therapeutics, Inc.
31 Dec 18
4
Edge Therapeutics, Inc.
15 Aug 18
4
Edge Therapeutics, Inc.
20 Jun 18
4
Edge Therapeutics, Inc.
5 Mar 18
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
28 Dec 23 | FRTX Fresh Tracks Therapeutics | RSU Common Stock | Sale back to company | Dispose D | No | No | 0.91 | 1,250 | 1.14 k | 0 |
24 Jan 23 | FRTX Fresh Tracks Therapeutics | RSU Common Stock | Grant | Acquire A | No | No | 0 | 1,250 | 0.00 | 1,250 |